CMG
57
-3
IP
53
5
PAYX
44
-6
DE
63
5
NOC
35
-2
KEY
39
6
MAT
49
2
ROK
44
-2
WDC
41
3
UPS
33
3
VZ
40
-2
ADI
60
5
AN
58
4
VRSK
61
-2
CCI
25
-3
KIM
48
-6
DTE
75
3
MPC
44
5
PLD
56
13
DD
56
-4
CMG
57
-3
IP
53
5
PAYX
44
-6
DE
63
5
NOC
35
-2
KEY
39
6
MAT
49
2
ROK
44
-2
WDC
41
3
UPS
33
3
VZ
40
-2
ADI
60
5
AN
58
4
VRSK
61
-2
CCI
25
-3
KIM
48
-6
DTE
75
3
MPC
44
5
PLD
56
13
DD
56
-4
Financhill
Back

Starwood Property Trust Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
61

STWD
Starwood Property Trust

Last Price:
$19.78
Seasonality Move:
-2.21%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Buy
61
Starwood Property Trust (STWD) is a Buy

Is Starwood Property Trust a Buy, Sell or Hold?

  • The current Starwood Property Trust [STWD] share price is $19.79. The Score for STWD is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • STWD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STWD Stock Price Chart

What is Starwood Property Trust's stock price today?

  • The Starwood Property Trust share price today is $19.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STWD is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

STWD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 58.08 Buy
Chaikin Money Flow: -190530 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.96 - 19.64) Buy
Bollinger Bands (100): (19.21 - 20.21) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

STWD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.65 Buy
20-day SMA: 19.41 Buy
50-day SMA: 19.45 Buy
200-day SMA: 19.71 Buy
8-day EMA: 19.61 Buy
20-day EMA: 19.47 Buy
50-day EMA: 19.47 Buy
200-day EMA: 19.69 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Starwood Property Trust Earnings Growth & STWD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.04 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Starwood Property Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):